ArticleDiscover oncology2025

Integrative multi-omics analysis identifies AEBP1 and EFEMP2 as key regulators of immune heterogeneity and therapeutic response in glioblastoma.

Yi Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.